Data from Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies

<div>Abstract<p>Ionizing radiotherapy (RT) is a widely used treatment strategy for malignancies. In solid tumors, RT-induced double-strand breaks lead to the accumulation of insertion-deletions (indels; ID), and their repair by nonhomologous end joining has been linked to the ID8 mutational signature in surviving cells. However, the extent of RT-induced mutagenesis in hematologic malignancies and its impact on their mutational profiles and interplay with commonly used chemotherapies has not yet been explored. In this study, we interrogated 580 whole-genome sequence (WGS) samples from patients with large B-cell lymphoma, multiple myeloma, and myeloid neoplasms and identified ID8 only in relapsed disease. Yet ID8 was detected after exposure to both RT and mutagenic chemotherapy (i.e., platinum and melphalan). Using WGS of single-cell colonies derived from treated lymphoma cells, we revealed a dose–response relationship between RT and platinum and ID8. Finally, using ID8 as a genomic barcode, we demonstrate that a single RT-surviving cell may seed distant relapse.</p>Significance:<p>RT and the ID8 indel signature are related, but their genomic impact on hematologic malignancies is unclear. Leveraging WGS, we linked ID8 to both RT and mutagenic chemotherapy and validated that platinum can induce ID8. We used ID8 as a genomic barcode to reveal that RT-resistant cells may seed systemic relapse.</p></div>

Authors

Publication Details

Published
2025-09-03
DOI
https://doi.org/10.1158/2643-3230.c.8014461
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Data from Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies

Benjamin T. Diamond, Michael David Jain, Kylee H. Maclachlan, Saad Z. Usmani et al.
Cancer Genomics and Diagnostics
article

Data from Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies

Benjamin T. Diamond, Michael David Jain, Kylee H. Maclachlan, Saad Z. Usmani, Frederick Lundry Locke, Katja Christina Weisel, Nicholas Figura, Alexandra M. Poos, Faith E. Davies, Dhanvantri Chahar, Bachisio Ziccheddu, Niels Weinhold, Hartmut Goldschmidt, Marios Papadimitriou, Jonathan Harry Schatz, Marcella Kaddoura, Marc S. Raab, Michael Durante, K. Elias, Tomáš Jelı́nek, Ola Landgren, Roland Fenk, Francesco Maura, Gareth J. Morgan
article en

Abstract

<div>Abstract<p>Ionizing radiotherapy (RT) is a widely used treatment strategy for malignancies. In solid tumors, RT-induced double-strand breaks lead to the accumulation of insertion-deletions (indels; ID), and their repair by nonhomologous end joining has been linked to the ID8 mutational signature in surviving cells. However, the extent of RT-induced mutagenesis in hematologic malignancies and its impact on their mutational profiles and interplay with commonly used chemotherapies has not yet been explored. In this study, we interrogated 580 whole-genome sequence (WGS) samples from patients with large B-cell lymphoma, multiple myeloma, and myeloid neoplasms and identified ID8 only in relapsed disease. Yet ID8 was detected after exposure to both RT and mutagenic chemotherapy (i.e., platinum and melphalan). Using WGS of single-cell colonies derived from treated lymphoma cells, we revealed a dose–response relationship between RT and platinum and ID8. Finally, using ID8 as a genomic barcode, we demonstrate that a single RT-surviving cell may seed distant relapse.</p>Significance:<p>RT and the ID8 indel signature are related, but their genomic impact on hematologic malignancies is unclear. Leveraging WGS, we linked ID8 to both RT and mutagenic chemotherapy and validated that platinum can induce ID8. We used ID8 as a genomic barcode to reveal that RT-resistant cells may seed systemic relapse.</p></div>

Openalex Percentile: Top 71%
Cancer Genomics and Diagnostics
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.